227 related articles for article (PubMed ID: 14751040)
21. Oral liquid levothyroxine treatment at breakfast: a mistake?
Cappelli C; Pirola I; Gandossi E; Formenti A; Castellano M
Eur J Endocrinol; 2014 Jan; 170(1):95-9. PubMed ID: 24123095
[TBL] [Abstract][Full Text] [Related]
22. Multiple level C in vitro/in vivo correlation of dissolution profiles of two L-thyroxine tablets with pharmacokinetics data obtained from patients treated for hypothyroidism.
Volpato NM; Silva RL; Brito AP; Gonçalves JC; Vaisman M; Noël F
Eur J Pharm Sci; 2004 Apr; 21(5):655-60. PubMed ID: 15066666
[TBL] [Abstract][Full Text] [Related]
23. Pseudomalabsorption of levothyroxine: a case report.
Ogawa D; Otsuka F; Mimura U; Ueno A; Hashimoto H; Kishida M; Ogura T; Makino H
Endocr J; 2000 Feb; 47(1):45-50. PubMed ID: 10811292
[TBL] [Abstract][Full Text] [Related]
24. [Bioequivalence of L-thyroxine tablets and a liquid L-thyroxine solution in the treatment of hypothyroid patients].
Grussendorf M; Vaupel R; Wegscheider K
Med Klin (Munich); 2004 Nov; 99(11):639-44. PubMed ID: 15583873
[TBL] [Abstract][Full Text] [Related]
25. Clinical efficacy and pharmacokinetics of levothyroxine suppository in patients with hypothyroidism.
Kashiwagura Y; Uchida S; Tanaka S; Watanabe H; Masuzawa M; Sasaki T; Namiki N
Biol Pharm Bull; 2014; 37(4):666-70. PubMed ID: 24694613
[TBL] [Abstract][Full Text] [Related]
26. Effect of calcium carbonate on the absorption of levothyroxine.
Singh N; Singh PN; Hershman JM
JAMA; 2000 Jun; 283(21):2822-5. PubMed ID: 10838651
[TBL] [Abstract][Full Text] [Related]
27. Serum thyrotropin in primary hypothyroidism. A possible predictor of optimal daily levothyroxine dose in primary hypothyroidism.
Kabadi UM; Jackson T
Arch Intern Med; 1995 May; 155(10):1046-8. PubMed ID: 7748047
[TBL] [Abstract][Full Text] [Related]
28. Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series.
Fallahi P; Ferrari SM; Ruffilli I; Antonelli A
BMC Gastroenterol; 2016 Feb; 16():22. PubMed ID: 26965518
[TBL] [Abstract][Full Text] [Related]
29. Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch Study.
Ernst FR; Sandulli W; Elmor R; Welstead J; Sterman AB; Lavan M
Drugs R D; 2017 Mar; 17(1):103-115. PubMed ID: 27943146
[TBL] [Abstract][Full Text] [Related]
30. Estimation of a physiologic replacement dose of levothyroxine in elderly patients with hypothyroidism.
Davis FB; LaMantia RS; Spaulding SW; Wehmann RE; Davis PJ
Arch Intern Med; 1984 Sep; 144(9):1752-4. PubMed ID: 6433829
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
[TBL] [Abstract][Full Text] [Related]
32. Effect of vitamin C on the absorption of levothyroxine in patients with hypothyroidism and gastritis.
Jubiz W; Ramirez M
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1031-4. PubMed ID: 24601693
[TBL] [Abstract][Full Text] [Related]
33. [Levothyroxine malabsortion].
Catalina PF; Carpio D
Med Clin (Barc); 2015 Jul; 145(1):46. PubMed ID: 25458511
[No Abstract] [Full Text] [Related]
34. Unawareness of the effects of soy intake on the management of congenital hypothyroidism.
Fruzza AG; Demeterco-Berggren C; Jones KL
Pediatrics; 2012 Sep; 130(3):e699-702. PubMed ID: 22908106
[TBL] [Abstract][Full Text] [Related]
35. New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.
Green WL
AAPS J; 2005 Mar; 7(1):E54-8. PubMed ID: 16146330
[TBL] [Abstract][Full Text] [Related]
36. Lactose intolerance revealed by severe resistance to treatment with levothyroxine.
Muñoz-Torres M; Varsavsky M; Alonso G
Thyroid; 2006 Nov; 16(11):1171-3. PubMed ID: 17123345
[TBL] [Abstract][Full Text] [Related]
37. Drug interactions in users of tablet vs. oral liquid levothyroxine formulations: a real-world evidence study in primary care.
Guglielmi V; Bellia A; Bianchini E; Medea G; Cricelli I; Sbraccia P; Lauro D; Cricelli C; Lapi F
Endocrine; 2018 Mar; 59(3):585-592. PubMed ID: 28905202
[TBL] [Abstract][Full Text] [Related]
38. Serum thyrotropin levels following levothyroxine administration at breakfast.
Perez CL; Araki FS; Graf H; de Carvalho GA
Thyroid; 2013 Jul; 23(7):779-84. PubMed ID: 23363386
[TBL] [Abstract][Full Text] [Related]
39. The Levothyroxine Absorption Test: A Four-Year Experience (2015-2018) at The Mayo Clinic.
Gonzales KM; Stan MN; Morris JC; Bernet V; Castro MR
Thyroid; 2019 Dec; 29(12):1734-1742. PubMed ID: 31680654
[No Abstract] [Full Text] [Related]
40. Bioequivalence study of levothyroxine tablets compared to reference tablets and an oral solution.
Koytchev R; Lauschner R
Arzneimittelforschung; 2004; 54(10):680-4. PubMed ID: 15553108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
